$EMLR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Talon Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Talon Therapeutics, Inc.. Get notifications about new insider transactions in Talon Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 27 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.94 | 42,142 | 39,613 | 1,383,670 | 1.4 M to 1.4 M (-2.96 %) |
Jun 27 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.94 | 26,160 | 24,590 | 858,914 | 885.1 K to 858.9 K (-2.96 %) |
Jun 27 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.07 | 20,378 | 21,804 | 670,504 | 690.9 K to 670.5 K (-2.95 %) |
Jun 27 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.07 | 11,320 | 12,112 | 359,757 | 371.1 K to 359.8 K (-3.05 %) |
Jun 15 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.02 | 14,724 | 15,018 | 1,425,812 | 1.4 M to 1.4 M (-1.02 %) |
Jun 15 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.02 | 9,139 | 9,322 | 885,074 | 894.2 K to 885.1 K (-1.02 %) |
Jun 15 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.02 | 5,685 | 5,799 | 690,882 | 696.6 K to 690.9 K (-0.82 %) |
Jun 15 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.02 | 3,633 | 3,706 | 371,077 | 374.7 K to 371.1 K (-0.97 %) |
Jun 07 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.03 | 24,398 | 25,130 | 1,440,536 | 1.5 M to 1.4 M (-1.67 %) |
Jun 07 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.03 | 15,145 | 15,599 | 894,213 | 909.4 K to 894.2 K (-1.67 %) |
Jun 07 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.03 | 9,429 | 9,712 | 696,597 | 706 K to 696.6 K (-1.34 %) |
Jun 07 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.03 | 6,028 | 6,209 | 374,710 | 380.7 K to 374.7 K (-1.58 %) |
Jun 07 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.02 | 19,081 | 19,463 | 1,464,934 | 1.5 M to 1.5 M (-1.29 %) |
Jun 07 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.02 | 11,844 | 12,081 | 909,358 | 921.2 K to 909.4 K (-1.29 %) |
Jun 07 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.02 | 7,367 | 7,514 | 705,996 | 713.4 K to 706 K (-1.03 %) |
Jun 07 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.02 | 4,708 | 4,802 | 380,738 | 385.4 K to 380.7 K (-1.22 %) |
Jun 07 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.01 | 4,052 | 4,093 | 1,484,015 | 1.5 M to 1.5 M (-0.27 %) |
Jun 07 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.01 | 2,514 | 2,539 | 921,202 | 923.7 K to 921.2 K (-0.27 %) |
Jun 07 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.01 | 1,564 | 1,580 | 713,363 | 714.9 K to 713.4 K (-0.22 %) |
Jun 07 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.01 | 1,000 | 1,010 | 385,446 | 386.4 K to 385.4 K (-0.26 %) |
May 24 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 124,688 | 124,688 | 1,573,653 | 1.7 M to 1.6 M (-7.34 %) |
May 24 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 77,399 | 77,399 | 976,841 | 1.1 M to 976.8 K (-7.34 %) |
May 24 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 48,135 | 48,135 | 747,966 | 796.1 K to 748 K (-6.05 %) |
May 24 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 30,779 | 30,779 | 407,568 | 438.3 K to 407.6 K (-7.02 %) |
May 24 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 7,192 | 7,192 | 1,698,341 | 1.7 M to 1.7 M (-0.42 %) |
May 24 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 4,464 | 4,464 | 1,054,240 | 1.1 M to 1.1 M (-0.42 %) |
May 24 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 2,777 | 2,777 | 796,101 | 798.9 K to 796.1 K (-0.35 %) |
May 24 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 1,774 | 1,774 | 438,347 | 440.1 K to 438.3 K (-0.40 %) |
May 24 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 21,741 | 21,524 | 1,705,533 | 1.7 M to 1.7 M (-1.26 %) |
May 24 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 13,495 | 13,360 | 1,058,704 | 1.1 M to 1.1 M (-1.26 %) |
May 24 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 4,694 | 4,694 | 798,878 | 803.6 K to 798.9 K (-0.58 %) |
May 24 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 3,000 | 3,000 | 440,121 | 443.1 K to 440.1 K (-0.68 %) |
May 24 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 12,159 | 12,159 | 1,727,274 | 1.7 M to 1.7 M (-0.70 %) |
May 24 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.00 | 7,547 | 7,547 | 1,072,199 | 1.1 M to 1.1 M (-0.70 %) |
May 24 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 8,394 | 8,310 | 803,572 | 812 K to 803.6 K (-1.03 %) |
May 24 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 5,365 | 5,311 | 443,121 | 448.5 K to 443.1 K (-1.20 %) |
May 31 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 11,667 | 11,550 | 1,488,067 | 1.5 M to 1.5 M (-0.78 %) |
May 31 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 7,242 | 7,170 | 923,716 | 931 K to 923.7 K (-0.78 %) |
May 31 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 4,504 | 4,459 | 714,927 | 719.4 K to 714.9 K (-0.63 %) |
May 31 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 2,879 | 2,850 | 386,446 | 389.3 K to 386.4 K (-0.74 %) |
May 31 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 19,836 | 19,638 | 1,499,734 | 1.5 M to 1.5 M (-1.31 %) |
May 31 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 12,312 | 12,189 | 930,958 | 943.3 K to 931 K (-1.31 %) |
May 31 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 7,657 | 7,580 | 719,431 | 727.1 K to 719.4 K (-1.05 %) |
May 31 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 0.99 | 4,895 | 4,846 | 389,325 | 394.2 K to 389.3 K (-1.24 %) |
May 31 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.01 | 54,083 | 54,624 | 1,519,570 | 1.6 M to 1.5 M (-3.44 %) |
May 31 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.01 | 33,571 | 33,907 | 943,270 | 976.8 K to 943.3 K (-3.44 %) |
May 31 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.01 | 20,878 | 21,087 | 727,088 | 748 K to 727.1 K (-2.79 %) |
May 31 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.01 | 13,348 | 13,481 | 394,220 | 407.6 K to 394.2 K (-3.28 %) |
May 19 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.11 | 23,092 | 25,632 | 1,739,433 | 1.8 M to 1.7 M (-1.31 %) |
May 19 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.11 | 14,334 | 15,911 | 1,079,746 | 1.1 M to 1.1 M (-1.31 %) |
May 19 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.11 | 8,915 | 9,896 | 811,966 | 820.9 K to 812 K (-1.09 %) |
May 19 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.11 | 5,698 | 6,325 | 448,486 | 454.2 K to 448.5 K (-1.25 %) |
May 19 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.11 | 34,061 | 37,808 | 1,762,525 | 1.8 M to 1.8 M (-1.90 %) |
May 19 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.11 | 21,143 | 23,469 | 1,094,080 | 1.1 M to 1.1 M (-1.90 %) |
May 19 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.11 | 13,149 | 14,595 | 820,881 | 834 K to 820.9 K (-1.58 %) |
May 19 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.11 | 8,406 | 9,331 | 454,184 | 462.6 K to 454.2 K (-1.82 %) |
May 19 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.12 | 74,913 | 83,903 | 1,796,586 | 1.9 M to 1.8 M (-4.00 %) |
May 19 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.12 | 46,501 | 52,081 | 1,115,223 | 1.2 M to 1.1 M (-4.00 %) |
May 19 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.12 | 28,919 | 32,389 | 834,030 | 862.9 K to 834 K (-3.35 %) |
May 19 2011 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Sell | S | 1.12 | 18,489 | 20,708 | 462,590 | 481.1 K to 462.6 K (-3.84 %) |
Apr 05 2011 | EMLR | Talon Therapeutics ... | Spiegel Robert J. | Director | Option Exercise | A | 0.77 | 35,000 | 26,950 | 35,000 | |
Apr 05 2011 | EMLR | Talon Therapeutics ... | Furst Howard P. | Director | Option Exercise | A | 0.77 | 35,000 | 26,950 | 35,000 | |
Apr 05 2011 | EMLR | Talon Therapeutics ... | DeSilva Nishan M | Director | Option Exercise | A | 0.77 | 35,000 | 26,950 | 35,000 | |
Apr 05 2011 | EMLR | Talon Therapeutics ... | Ferrer Andrew | Director | Option Exercise | A | 0.77 | 35,000 | 26,950 | 35,000 | |
Apr 05 2011 | EMLR | Talon Therapeutics ... | LEFF JONATHAN S | Director | Option Exercise | A | 0.77 | 35,000 | 26,950 | 35,000 | |
Apr 05 2011 | EMLR | Talon Therapeutics ... | MAIER PAUL V | Director | Option Exercise | A | 0.77 | 47,000 | 36,190 | 47,000 | |
Apr 05 2011 | EMLR | Talon Therapeutics ... | Rosenberg Leon E | Director | Option Exercise | A | 0.77 | 65,000 | 50,050 | 65,000 | |
Feb 04 2011 | EMLR | Talon Therapeutics ... | DEITCHER STEVEN R | President & CEO | Option Exercise | A | 0.76 | 62,500 | 47,500 | 312,500 | |
Feb 04 2011 | EMLR | Talon Therapeutics ... | DEITCHER STEVEN R | President & CEO | Grant | A | 0.00 | 179,192 | 0 | 184,192 | 5 K to 184.2 K (+3,583.84 %) |
Dec 23 2010 | EMLR | Talon Therapeutics ... | CARLSON CRAIG W | Chief Financial Off ... | Option Exercise | A | 0.50 | 705,000 | 348,975 | 705,000 | |
Dec 23 2010 | EMLR | Talon Therapeutics ... | NIELSEN TYLER MARSHALL | Interim CFO | Option Exercise | A | 0.50 | 67,500 | 33,413 | 67,500 | |
Dec 23 2010 | EMLR | Talon Therapeutics ... | DEITCHER STEVEN R | President & CEO | Option Exercise | A | 0.50 | 1,635,000 | 809,325 | 1,635,000 | |
Sep 14 2010 | EMLR | Talon Therapeutics ... | WARBURG PINCUS & CO | Director | Option Exercise | A | 0.74 | 11,307 | 8,322 | 371,307 | |
Sep 14 2010 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | A | 0.74 | 135 | 99 | 4,448 | |
Sep 14 2010 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | A | 0.74 | 73 | 54 | 2,426 | |
Sep 14 2010 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | A | 0.74 | 646 | 475 | 21,213 | |
Sep 14 2010 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | A | 0.74 | 401 | 295 | 13,168 | |
Sep 14 2010 | EMLR | Talon Therapeutics ... | LEFF JONATHAN S | Director | Option Exercise | A | 0.74 | 11,307 | 8,322 | 371,307 | |
Aug 03 2010 | EMLR | Talon Therapeutics ... | LEFF JONATHAN S | Director | Option Exercise | A | 0.17 | 40,000 | 6,800 | 40,000 | |
Aug 03 2010 | EMLR | Talon Therapeutics ... | Ferrer Andrew | Director | Option Exercise | A | 0.17 | 40,000 | 6,800 | 40,000 | |
Aug 03 2010 | EMLR | Talon Therapeutics ... | DeSilva Nishan M | Director | Option Exercise | A | 0.17 | 40,000 | 6,800 | 40,000 | |
Aug 03 2010 | EMLR | Talon Therapeutics ... | Spiegel Robert J. | Director | Option Exercise | A | 0.17 | 40,000 | 6,800 | 40,000 | |
Jun 09 2010 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | P | 0.13 | 4,313 | 556 | 4,313 | |
Jun 09 2010 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | P | 0.13 | 2,353 | 303 | 2,353 | |
Jun 09 2010 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | P | 0.13 | 20,567 | 2,649 | 20,567 | |
Jun 09 2010 | EMLR | Talon Therapeutics ... | Flynn James E | Director | Option Exercise | P | 0.13 | 12,767 | 1,644 | 12,767 | |
Jun 09 2010 | EMLR | Talon Therapeutics ... | DEITCHER STEVEN R | President & CEO | Option Exercise | A | 0.23 | 350,000 | 80,500 | 350,000 | |
Jun 09 2010 | EMLR | Talon Therapeutics ... | CARLSON CRAIG W | Chief Financial Off ... | Option Exercise | A | 0.23 | 250,000 | 57,500 | 250,000 | |
Feb 19 2010 | EMLR | Talon Therapeutics ... | WIESINGER LINDA | Director | Option Exercise | A | 0.19 | 40,000 | 7,600 | 40,000 | |
Feb 19 2010 | EMLR | Talon Therapeutics ... | MAIER PAUL V | Director | Option Exercise | A | 0.19 | 50,000 | 9,500 | 50,000 | |
Feb 18 2010 | EMLR | Talon Therapeutics ... | WEISER MICHAEL | Director | Option Exercise | A | 0.19 | 40,000 | 7,600 | 40,000 | |
Feb 18 2010 | EMLR | Talon Therapeutics ... | Rosenberg Leon E | Director | Option Exercise | A | 0.19 | 75,000 | 14,250 | 75,000 | |
Feb 18 2010 | EMLR | Talon Therapeutics ... | NIELSEN TYLER MARSHALL | Interim CFO | Option Exercise | A | 0.19 | 40,000 | 7,600 | 40,000 | |
Feb 18 2010 | EMLR | Talon Therapeutics ... | HAGEY ANNE E | VP, Chief Medical O ... | Option Exercise | A | 0.19 | 350,000 | 66,500 | 350,000 | |
Feb 18 2010 | EMLR | Talon Therapeutics ... | Furst Howard P. | Director | Option Exercise | A | 0.19 | 40,000 | 7,600 | 40,000 | |
Feb 18 2010 | EMLR | Talon Therapeutics ... | DEITCHER STEVEN R | President & CEO | Option Exercise | A | 0.19 | 1,000,000 | 190,000 | 1,000,000 | |
Feb 26 2009 | EMLR | Talon Therapeutics ... | WEISER MICHAEL | Director | Option Exercise | A | 0.14 | 40,000 | 5,600 | 40,000 | |
Feb 26 2009 | EMLR | Talon Therapeutics ... | WIESINGER LINDA | Director | Option Exercise | A | 0.14 | 40,000 | 5,600 | 40,000 | |
Feb 26 2009 | EMLR | Talon Therapeutics ... | DEITCHER STEVEN R | President & CEO | Option Exercise | A | 0.14 | 300,000 | 42,000 | 300,000 | |
Feb 26 2009 | EMLR | Talon Therapeutics ... | MAIER PAUL V | Director | Option Exercise | A | 0.14 | 50,000 | 7,000 | 50,000 | |
Feb 26 2009 | EMLR | Talon Therapeutics ... | Rosenberg Leon E | Director | Option Exercise | A | 0.14 | 75,000 | 10,500 | 75,000 | |
Feb 26 2009 | EMLR | Talon Therapeutics ... | HAGEY ANNE E | VP, Chief Medical O ... | Option Exercise | A | 0.14 | 150,000 | 21,000 | 150,000 | |
Feb 26 2009 | EMLR | Talon Therapeutics ... | NIELSEN TYLER MARSHALL | Controller | Option Exercise | A | 0.14 | 25,000 | 3,500 | 25,000 | |
Feb 26 2009 | EMLR | Talon Therapeutics ... | Iparraguirre John | Vice President & CF ... | Option Exercise | A | 0.14 | 75,000 | 10,500 | 75,000 | |
Feb 26 2009 | EMLR | Talon Therapeutics ... | Belldegrun Arie | Director | Option Exercise | A | 0.14 | 40,000 | 5,600 | 40,000 | |
Aug 21 2008 | EMLR | Talon Therapeutics ... | HAGEY ANNE E | VP, Chief Medical O ... | Buy | L | 0.62 | 100 | 62 | 100 | 0 to 100 |
Jun 18 2008 | EMLR | Talon Therapeutics ... | MAIER PAUL V | Director | Buy | P | 0.75 | 7,000 | 5,250 | 7,000 | 0 to 7 K |
Jun 17 2008 | EMLR | Talon Therapeutics ... | MAIER PAUL V | Director | Option Exercise | A | 0.73 | 10,000 | 7,300 | 10,000 | |
Apr 25 2008 | EMLR | Talon Therapeutics ... | HAGEY ANNE E | VP, Chief Medical O ... | Option Exercise | A | 1.04 | 200,000 | 208,000 | 200,000 | |
May 15 2008 | EMLR | Talon Therapeutics ... | WEISER MICHAEL | Director | Buy | P | 0.84 | 6,000 | 5,040 | 561,667 | 555.7 K to 561.7 K (+1.08 %) |
May 15 2008 | EMLR | Talon Therapeutics ... | WEISER MICHAEL | Director | Buy | P | 0.85 | 4,000 | 3,400 | 555,667 | 551.7 K to 555.7 K (+0.73 %) |
Mar 21 2008 | EMLR | Talon Therapeutics ... | MAIER PAUL V | Director | Option Exercise | A | 0.90 | 40,000 | 36,000 | 40,000 | |
Dec 31 2007 | EMLR | Talon Therapeutics ... | DEITCHER STEVEN R | President and CEO | Buy | P | 1.10 | 5,000 | 5,500 | 20,000 | 15 K to 20 K (+33.33 %) |
Dec 31 2007 | EMLR | Talon Therapeutics ... | DEITCHER STEVEN R | President and CEO | Buy | P | 1.03 | 5,000 | 5,150 | 15,000 | 10 K to 15 K (+50.00 %) |
Dec 27 2007 | EMLR | Talon Therapeutics ... | DEITCHER STEVEN R | President and CEO | Buy | P | 1.07 | 5,000 | 5,345 | 10,000 | 5 K to 10 K (+100.00 %) |
Dec 27 2007 | EMLR | Talon Therapeutics ... | DEITCHER STEVEN R | President and CEO | Buy | P | 1.08 | 5,000 | 5,400 | 5,000 | 0 to 5 K |
Dec 18 2007 | EMLR | Talon Therapeutics ... | WIESINGER LINDA | Director | Option Exercise | A | 1.12 | 40,000 | 44,800 | 40,000 | |
Dec 18 2007 | EMLR | Talon Therapeutics ... | Belldegrun Arie | Director | Option Exercise | A | 1.12 | 40,000 | 44,800 | 40,000 | |
Dec 18 2007 | EMLR | Talon Therapeutics ... | WEISER MICHAEL | Director | Option Exercise | A | 1.12 | 40,000 | 44,800 | 40,000 | |
Dec 18 2007 | EMLR | Talon Therapeutics ... | DEITCHER STEVEN R | President and CEO | Option Exercise | A | 1.12 | 650,000 | 728,000 | 650,000 | |
Dec 18 2007 | EMLR | Talon Therapeutics ... | NIELSEN TYLER MARSHALL | Controller | Option Exercise | A | 1.12 | 50,000 | 56,000 | 50,000 | |
Dec 18 2007 | EMLR | Talon Therapeutics ... | Rosenberg Leon E | Director | Option Exercise | A | 1.12 | 75,000 | 84,000 | 75,000 | |
Dec 18 2007 | EMLR | Talon Therapeutics ... | Iparraguirre John | Vice President, CFO | Option Exercise | A | 1.12 | 110,000 | 123,200 | 110,000 | |
Dec 18 2007 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Option Exercise | A | 1.12 | 40,000 | 44,800 | 40,000 | |
Dec 07 2007 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Sell | S | 1.16 | 8,000 | 9,280 | 83,804 | 91.8 K to 83.8 K (-8.71 %) |
Dec 07 2007 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Sell | S | 1.18 | 12,000 | 14,160 | 91,804 | 103.8 K to 91.8 K (-11.56 %) |
Dec 07 2007 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Sell | S | 1.20 | 8,100 | 9,720 | 103,804 | 111.9 K to 103.8 K (-7.24 %) |
Dec 07 2007 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Sell | S | 1.21 | 100 | 121 | 111,904 | 112 K to 111.9 K (-0.09 %) |
Nov 20 2007 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Sell | S | 1.45 | 7,838 | 11,365 | 112,004 | 119.8 K to 112 K (-6.54 %) |
Nov 20 2007 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Sell | S | 1.46 | 500 | 730 | 119,842 | 120.3 K to 119.8 K (-0.42 %) |
Aug 28 2007 | EMLR | Talon Therapeutics ... | DEITCHER STEVEN R | President and CEO | Option Exercise | A | 1.74 | 100,000 | 174,000 | 100,000 | |
Jun 28 2007 | EMLR | Talon Therapeutics ... | NIELSEN TYLER MARSHALL | Controller | Option Exercise | A | 1.66 | 25,000 | 41,500 | 25,000 | |
May 23 2007 | EMLR | Talon Therapeutics ... | DEITCHER STEVEN R | Executive V.P., CMO | Option Exercise | A | 1.65 | 400,000 | 660,000 | 400,000 | |
Apr 19 2007 | EMLR | Talon Therapeutics ... | Rosenberg Leon E | Director | Option Exercise | A | 2.04 | 35,000 | 71,400 | 35,000 | |
Feb 27 2007 | EMLR | Talon Therapeutics ... | WIESINGER LINDA | Director | Option Exercise | A | 4.97 | 40,000 | 198,800 | 40,000 | |
Jan 24 2007 | EMLR | Talon Therapeutics ... | Berk Gregory | Senior VP & Chief M ... | Option Exercise | A | 6.82 | 75,000 | 511,500 | 75,000 | |
Jan 24 2007 | EMLR | Talon Therapeutics ... | Berk Gregory | Senior VP & Chief M ... | Option Exercise | D | 6.82 | 125,000 | 852,500 | 0 | |
Dec 18 2006 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Option Exercise | A | 6.82 | 50,000 | 341,000 | 50,000 | |
Dec 18 2006 | EMLR | Talon Therapeutics ... | Rosenberg Leon E | Director | Option Exercise | A | 6.82 | 40,000 | 272,800 | 40,000 | |
Dec 18 2006 | EMLR | Talon Therapeutics ... | NIELSEN TYLER MARSHALL | Controller | Option Exercise | A | 6.82 | 65,000 | 443,300 | 65,000 | |
Dec 18 2006 | EMLR | Talon Therapeutics ... | Belldegrun Arie | Director | Option Exercise | A | 6.82 | 40,000 | 272,800 | 40,000 | |
Dec 18 2006 | EMLR | Talon Therapeutics ... | Iparraguirre John | Vice President, CFO | Option Exercise | A | 6.82 | 125,000 | 852,500 | 125,000 | |
Dec 18 2006 | EMLR | Talon Therapeutics ... | WEISER MICHAEL | Director | Option Exercise | A | 6.82 | 40,000 | 272,800 | 40,000 | |
Dec 18 2006 | EMLR | Talon Therapeutics ... | Vitale Fred | VP - Chief Business ... | Option Exercise | A | 6.82 | 125,000 | 852,500 | 125,000 | |
Dec 18 2006 | EMLR | Talon Therapeutics ... | Berk Gregory | Senior VP & Chief M ... | Option Exercise | A | 6.82 | 125,000 | 852,500 | 125,000 | |
Dec 18 2006 | EMLR | Talon Therapeutics ... | Ahn Mark J | President and CEO | Option Exercise | A | 6.82 | 175,000 | 1,193,500 | 175,000 | |
Aug 31 2006 | EMLR | Talon Therapeutics ... | Berk Gregory | Chief Medical Offic ... | Grant | A | 0.00 | 22,000 | 0 | 22,000 | 0 to 22 K |
Jul 31 2006 | EMLR | Talon Therapeutics ... | Rosenberg Leon E | Director | Buy | P | 6.55 | 800 | 5,240 | 1,000 | 200 to 1,000 (+400.00 %) |
Jul 31 2006 | EMLR | Talon Therapeutics ... | Rosenberg Leon E | Director | Buy | P | 6.53 | 200 | 1,306 | 200 | 0 to 200 |
Jul 18 2006 | EMLR | Talon Therapeutics ... | KIER ISAAC | Director | Buy | P | 6.47 | 4,600 | 29,762 | 7,000 | 2.4 K to 7 K (+191.67 %) |